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Phenacetin can be metabolized to reactive metabolites by a variety of mechanisms. (1) Phenacetin
can be N-hydroxylated, and the resulting N-hydroxyphenacetin can be sulfated or glucuronidated.
Whereas phenacetin N-0 sulfate immediately rearranges to form a reactive metabolite which may
covalently bind to protein, phenacetin N-0 glucuronide slowly rearranges to form reactive metabo-
lites. Incubation of the purified phenacetin N-0 glucuronide under a variety of conditions suggests
thatN-acetyl-p-benzoquinone imine is a reactive metabolite. This metabolite covalently binds to pro-
tein, reacts with glutathione to form an acetaminophen-glutathione conjugate, is reduced by ascor-
bate to acetaminophen or is partially hydrolyzed to acetamide. (2) Phenacetin can be 0-
deethylated to acetaminophen, and acetaminophen can be converted directly to a reactive metabo-
lite which may be also N-acetyl-p-benzoquinone imine. (3) Phenacetin can be sequentially N-
hydroxylated and 0-deethylated toN-hydroxyacetaminophen which spontaneously dehydrates to N-
acetyl-p-benzoquinone imine. (4) Phenacetin can be 3, 4-epoxidated to form an alkylating and an ar-
ylating metabolite. In the presence of glutathione, a S-ethylglutathione conjugate and an
acetaminophen-glutathione conjugate are formed. In the absence of glutathione, the alkylating
metabolite may bind to protein and the arylating metabolite is completely hydrolyzed to acetamide
and another arylating metabolite which may bind to protein. The structures of the alkylating and
arylating metabolites are unknown.
Control experiments have shown that in pathway (1) the phenolic oxygen of the acetaminophen-
glutathione conjugate is derived from water, whereas in pathways (2) and (3) the phenolic oxygen of
this metabolite is derived from phenacetin. In pathway (4) the phenolic oxygen was 50% derived
from molecular oxygen and 50% from phenacetin. Administration of [p-.'0]phenacetin to hamsters
revealed only a 10% loss of 1S0 in the acetaminophen mercapturic acid (the further metabolic prod-
uct of the glutathione conjugate) which suggests that, in the hamster, pathways (2) and/or (3) are the
primary mechanism of conversion of phenacetin to reactive metabolites in vivo.
Introduction
Phenacetin p-ethoxyacetanilide) and acetamino-
phen (paracetamol, p-hydroxyacetanilide) are two of
the more popular analgesic antipyretics. Acetamino-
phen was originally introduced in 1893, whereas
phenacetin was introduced as an analgesic in 1897
(1). Phenacetin has been a commonly used drug for
many years; however, acetaminophen has become a
widely used drug only in the last couple of decades
02.
While there has been a dramatic increase in acet-
aminophen consumption in recent years, there has
been a sharp decrease in worldwide use of phenace-
tin. This is primarily attributable to kidney toxici-
ties (analgesic nephropathy) and possible tumors as-
sociated with the abuse of phenacetin (3, 4). Abuse
of this drug has been defined as the consumption of
at least one gram per day for at least three years (3,
*National Center for Toxicological Research, Jefferson, AR
72079.
4). Analgesic nephropathy is characterized by inter-
stitial nephritis and progressive reduction in renal
size, secondary to repeated episodes of papillary ne-
crosis (3, 4). A high incidence of tumors of the uri-
nary tract has also been correlated with abuse of
this drug(5, 6).
An animal model for phenacetin-induced nephro-
toxicity has not been developed; however, in rats (7)
and hamsters (8) acute doses have been shown to
produce a centrilobular hepatic necrosis. Chronic ad-
ministration of phenacetin to rats has been recently
reported to produce tumors of the urinary tract (9).
The mechanism of these toxicities is unclear.
Acetaminophen, which is the primary phenacetin
metabolite, has not been shown to be carcinogenic,
but in acute doses it produces a centrilobular hepat-
ic necrosis in man and experimental animal (7, 10).
The toxicity is mediated by a reactive metabolite
which covalently binds to protein and is formed by
the cytochrome P-450 mixed function oxidase sys-
tem (11-14) (Fig. 1). Studies with analogs of acet-
aminophen have suggested that N-oxidation may beJ. A. HINSON
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FIGURE 1. Postulated mechanism for metabolism of acet-
aminophen.
an important step in conversion of acetaminophen
to the reactive metabolites (15-17). For example, it
was shown that the enzyme that N-hydroxylates p-
chloroacetanilide also may convert acetaminophen
to a reactive metabolite. Since Calder et al. (18)
showed that N-acetyl-p-benzoquinone imine was
electrophilic, it was postulated that acetaminophen
was N-hydroxylated and then immediately dehy-
drated to produce the reactive metabolite N-acetyl-
p-benzoquinone imine (19).
In this work we report mechanisms of formation
of reactive metabolites of phenacetin which may be
important in its toxicities, and in particular, the
mechanism of phenacetin-induced hepatic necrosis
in hamsters. Previous work on this hepatic toxicity
had suggested that this necrosis may be mediated
by a reactive metabolite which binds to protein (8).
Materials and Methods
Chemicals
N-Hydroxyphenacetin was synthesized by zinc re-
duction of p-nitrophenetole followed by acetylation
with acetyl chloride (17). Nitrosation of [180] phenol,
followed by reduction and acetylation, yielded [p-'8O]
acetaminophen. Treatment of the [p-80]acetamino-
phen with ethyl iodide yielded [p-O]phenacetin (20).
N-Hydroxyacetaminophen was a gift of Dr. Ian
Calder, University of Melbourne, Australia.
Assays
Metabolites were isolated, purified and quantified
by either high pressure liquid chromatography or
thin-layer chromatography. Microsomal incubation
mixtures were performed by using hamster liver
microsomes. Sulfation assays were conducted with
100,000g rat liver supernatant which had been
chromatographed on Sephadex G-25 to remove glu-
tathione (21). Glucuronidation assays were per-
formed by using Triton X-100-treated rat liver
microsomes (21).
Results and Discussion
N-Hydroxylation of Phenacetin
Previous work suggested that phenacetin-induced
hepatotoxicity in hamsters was mediated by a
reactive metabolite which covalently bound to
protein (8). Since N-oxidation of acetaminophen was
postulated to be an important step in acetamin-
ophen-induced hepatotoxicity (11-15,19), the
possibility was examined that phenacetin was N-
hydroxylated to form a reactive metabolite. N-
Hydroxyphenacetin was synthesized, and a chroma-
tographic assay was developed to separate N-hy-
droxyphenacetin from other known phenacetin
metabolites (17). A metabolite with the chromato-
graphic characteristics of N-hydroxyphenacetin was
isolated from an incubation mixture of phenacetin,
hamster liver microsomes, and NADPH. Mass spec-
tral analysis indicated that the metabolite had a
molecular ion and a fragmentation pattern identical
to that of synthetic N-hydroxyphenacetin (17). Com-
parison of the rate of phenacetin N-hydroxylation
(17) to phenacetin O-deethylation (acetaminophen
formation) (22) revealed that phenacetin was N-
hydroxylated at approximately 10% the rate it was
O-deethylated (Table 1). Whereas both activities
were stimulated by pretreatment of hamsters with
3-methylcholanthrene, only the O-deethylation activ-
ity was induced by phenobarbital pretreatment.
The possibility was also investigated that N-hy-
droxyphenacetin may be converted to a reactive
metabolite and be important in phenacetin-induced
hepatotoxicity. However, when [acetyl-"4CJN-hy-
droxyphenacetin was incubated in the presence or
Table 1. Effect of phenobarbital and 3-methylcholanthrene
pretreatment on the microsomal metabolism of phenacetin.a
Metabolic product,
nmole/min/mg microsomal protein
Treatment N-Hydroxyphenacetin Acetaminophen
None 0.24 2.3
Phenobarbital 0.25 4.5
3-Methylcholanthrene 0.39 5.5
aHamsters were pretreated with either phenobarbital or 3-
methylcholanthrene and rates ofN-hydroxylation (17) or O-de-
ethylation determined (22).
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absence of NADPH, covalent binding to protein was
not detected (17).
Conversion ofN-Hydroxyphenacetin to
Reactive Metabolites by Sulfation and
Glucuronidation
Since work in the Millers' laboratory showed that
sulfation of the N-hydroxy compounds may lead to
reactive metabolites (23), the role of sulfation or
glucuronidation in the formation of a reactive me-
tabolite was investigated. N-Hydroxyphenacetin
was readily sulfated and glucuronidated in in vitro
incubation mixtures (21). Furthermore, covalent
binding to protein was detected when [acetyl-'4C]N-
hydroxyphenacetin was used as a substrate (21, 24).
Whereas the N-O sulfate of N-hydroxyphenacetin
proved to be a very unstable intermediate, the
phenacetin N-O glucuronide was a semistable
compound which could be isolated in pure form.
When the purified phenacetin N-O glucuronide was
incubated in Tris bugger, pH 7.4 at 37°C, the half-life
was approximately 9.0 hr, and acetaminophen,
acetamide, phenacetin and 2-hydroxyphenacetin
glucuronide were identified as breakdown products.
Inclusion of ascorbic acid in the incubation mixture
increased acetaminophen formation and decreased
acetamide formation. In the presence of bovine
serum albumin, covalent binding to protein was
detected and acetaminophen and acetamide forma-
tion were inhibited. Glutathione inhibited covalent
binding to bovine serum albumin and an acetamino-
phen-glutathione conjugate was formed. It was thus
postulated that phenacetin N-O glucuronide
decomposed to yield N-acetyl-p-benzoquinone imine.
This metabolite could be reduced to acetaminophen,
covalently bind to protein, react with glutathione to
form an acetaminophen-glutathione conjugate or
hydrolyze to acetamide, plus presumably p-
benzoquinone. Neither ascorbic acid, bovine serum
albumin nor glutathione altered phenacetin and 2-
hydroxyphenacetin glucuronide formation. Thus,
the latter does not lead to N-acetyl-p-benzoquinone
imine (24).
Subsequent work suggested that multiple reac-
tive intermediates were formed during the break-
down of phenacetin N-O glucuronide (Fig. 2) (25).
When the phenacetin N-O glucuronide was allowed
to decompose in the presence of sodium phosphate,
pH 7.4, 3-hydroxyphenacetin phosphate was charac-
terized as a metabolite. This product was identified
through comparison of its chromatographic and
mass spectral properties to synthetic standards and
was apparently formed from an intermediate that
led to the postulated N-acetyl-p-benzoquinone imine.
Thus, increasing the phosphate buffer concentration
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FIGURE 2. Postulated mechanism for breakdown of phenace-
tin N-O-glucuronide.
in the incubation mixture increased 3-hydroxyphen-
acetin phosphate formation and decreased acetamin-
ophen and acetamide formation (Fig. 3). Phenacetin
and 2-hydroxyphenacetin glucuronide formation
were not altered by phosphate suggesting their for-
mation is unrelated to 3-hydroxyphenacetin phos-
phate. When phenacetin N-O glucuronide was incu-
bated in the presence of bovine serum albumin and
varying concentrations of phosphate buffer, cova-
lent binding to protein was inhibited (Fig. 4). Kinetic
analysis of these data (Figs. 3 and 4) indicated that
at infinite phosphate concentration, 40% of the total
breakdown products of phenacetin N-O glucuronide
could be trapped as 3-hydroxyphenacetin phosphate
and that acetamide formation could be completely
inhibited. Acetaminophen formation, however, could
be only partially inhibited (Fig. 3), because even at
high phosphate concentration 11% of the decompo-
sition products of phenacetin N-O glucuronide form-
ed acetaminophen. In the presence of bovine serum
albumin where acetaminophen formation was inhib-
ited, 11% of the decomposition products of phenace-
tin N-O glucuronide which were covalently bound
to protein could not be inhibited by phosphate.
These data suggested that covalent binding to pro-
tein may occur by two different reactive metabo-
lites. One reactive metabolite was trapped by phos-
phate, before it could release acetamide, while for-
mation of the other reactive metabolite was not af-
fected by phosphate. In the absence of bovine se-
rum albumin, both reactive metabolites were con-
verted to acetaminophen. The intermediate which
reacted with phosphate was postulated to be the ni-
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[experiments revealed that the phenolic oxygen of
acetaminophen and the acetaminophen-GSH conju-
H \/ Phenacetin gate were derived from H2`80 (20)]. The structure of
z the reactive metabolite which is not inhibitable by
u 20 phosphate is unknown. The postulated mechanisms
XL / \*of breakdown for phenacetin N-O glucuronide are
0 Acetaminophen presented in Figure 2 (25).
Evidence forN-Acetyl-p-Benzoquinone
Imine as the Reactive Metabolite
0 I tofAcetaminophen
Although N-acetyl-p-benzoquinone imine was pos-
Acetamide tulated to be the reactive metabolite of acetamino-
A : phen, no evidence was initially presented to support
this hypothesis (15, 19). Thus the data on the decom-
0 I position of phenacetin N-O glucuronide were very
0 0.1 0.2 0.3 0.4 0.5 revealing(24), because they suggested thatN-acetyl-
PHOSPHATE BUFFER, M p-benzoquinone imine may be the reactive metabo-
FIGURE 3. Effect of phosphate buffer on the breakdown of lite of acetaminophen which could covalently bind to
phenacetin N-O glucuronide. Purified phenacetin N-O gluc- protein or react with glutathione to form an acet-
uronide was allowed to break down in the presence of aminophen-glutathione conjugate. Moreover, the
0.05M Tris-HCl buffer, pH 7.4, and in the presence of data on the breakdown of phenacetin N-O glucuro-
varying concentrations of sodium phosphate, pH 7.4 (25). nide (24) suggested that ascorbic acid should block
covalent binding to protein of the reactive metabo-
lite of acetaminophen and that acetamide may be a
40 metabolite. Subsequent investigations showed that,
indeed, ascorbic acid could block covalent binding of
E the reactive metabolite of acetaminophen in micro-
' 30 \ somal incubation mixtures (2, 21, 26) (Fig. 5). Fur-
o thermore, acetamide was found to be a microsomal
z metabolite of acetaminophen (Fig. 6). Comparison of a
z ¢ \ l4C-acetamide formation to covalent binding of [14C_ o 20 iacetyl]acetaminophen to protein revealed that
Z 0 acetamide was formed at a rate of approximately
< 10 _, 25% the rate of covalentbinding (27).
O A An intermediate which could lead to the for-
u mation ofN-acetyl-p-benzoquinone isN-hydroxyacet-
_________________________________ aminophen. Indeed, initial work with the acetamino-
0 0.1 0.2 0.3 0.4 0.5 phen analogsp-chloroacetanilide (15, 16)and phenace-
tin (17) showed that these analogs were N-hydrox- PHOSPHATE BUFFER, M ylated, apparently by the same cytochrome P450
FIGURE 4. Effect of phosphate buffer on covalent binding to species which converted acetaminophen to a
protein of reactive metabolites formed during breakdown reactive metabolite. These data supported the
of phenacetin N-O glucuronide. Phenacetin N-O concept that acetaminophen was initially N-
glucuronide, 50 (A) or 100 (0) nmole, was incubated with 10
mg bovine serum albumin in a total volume of 1 mL of droyate andithat once formed, the N-hydroxy
0.05M Tris-HCl, pH 7.4, and varying amounts of sodium derivative immediately dehydrated to the reactive
phosphate, pH 7.4 (25). metabolite N-acetyl-p-benzoquinone imine. Fur-
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FIGURE 5. Effect of ascorbic acid on covalent binding to pro-
tein of microsomally generated reactive metabolite of acet-
aminophen. Radiolabeled acetaminophen was incubated
with hamster liver microsomes, an NADPH-generating
system and varying concentrations of ascorbic acid.
Ascorbic acid at these concentrations did not significantly
inhibit other cytochrome P-450 reactions such as ethyl
morphine N-demethylation or 3-hydroxylation of acet-
aminophen (26).
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FIGURE 6. Time course for microsomal conversion of [acetyl-
14C]acetaminophen to covalently bound metabolite and
acetamide. [Acetyl-"C]acetaminophen was incubated with
hamster liver microsomes and an NADPH-generating
system. Covalent binding was determined by a solvent
extraction assay whereas acetamide was determined by an
HPLC assay (2, 31).
thermore, when N-hydroxyacetaminophen was
synthesized by Healey et al. (28) and Gemborys et
al. (29), it was found to dehydrate to N-acetyl-p-
benzoquinone imine as was postulated. However,
the compound did not immediately dehydrate but
rather had a half-life of approximately 15 min, which
indicates that N-hydroxyacetaminophen may not be
a quantitatively important intermediate leading to
the acetaminophen reactive metabolite. Moreover,
N-hydroxyacetaminophen was not detected as a mi-
crosomal metabolite of acetaminophen; however, it
was detected as a microsomal metabolite of N-hy-
droxyphenacetin (Fig. 7) (30). Since more covalent
binding was detected with acetaminophen than with
N-hydroxyphenacetin, this suggested that acetamin-
ophen is not activated to a reactive metabolite via
N-hydroxyacetaminophen (29). Inasmuch as the data
indicated that N-acetyl-p-benzoquinone imine was
the reactive metabolite, it was postulated that acet-
aminophen was initially N-oxygenated at the active
site of cytochrome P450 and that this species broke
down, as shown in Figure 8, to yield N-acetyl-p-
benzoquinone imine instead of N-hydroxyacet-
aminophen (31).
Conversion of Phenacetin to Reactive
Metabolites by 3,4-Epoxidation
Incubation of [ring-3H]phenacetin with hamster
liver microsomes and NADPH led to covalent bind-
ing to the microsomal protein (22). Since inclusion of
an excess of unlabeled acetaminophen in the in-
cubation mixture did not decrease the amount of co-
valent binding, the binding is apparently not
mediated by an initial deethylation to acetamino-
phen followed by metabolism of acetaminophen.
Inclusion of glutathione in the microsomal in-
cubation mixture blocked covalent binding to
protein and a glutathione conjugate was formed.
Surprisingly, when the conjugate was analyzed, it
was an acetaminophen-glutathione conjugate. Since
Daly (32) had presented evidence that other
acetanilides, such as p-chloroacetanilide, may be
metabolized by 3,4-epoxidation, the possibility was
investigated that phenacetin may be analogously
3,4-epoxidated (22). If phenacetin 3,4-epoxide were
formed, it may rearrange, producing N-acetyl-p-
benzoquinone imine. The importance of this
mechanism was investigated by incubating
phenacetin with microsomes, NADPH and glutathi-
one in the presence of a molecular oxygen-18 at-
mosphere. If 3,4-epoxidation were the mechanism of
activation of phenacetin, 180 may be expected to be
quantitatively incorporated into the phenolic
oxygen of the acetaminophen-glutathione conjugate.
Mass spectral analysis of the acetaminophen-
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FIGURE 7. Time course of N-hydroxyacetaminophen for-
mation and covalent binding during the microsomal metab-
olism of acetaminophen and N-hydroxyphenacetin. Radio-
labeled acetaminophen or radiolabeled N-hydroxyphenace-
tin was incubated with hamster liver microsomes and
NADPH. At the indicated time either covalent binding to
protein or N-hydroxyacetaminophen formation was mea-
sured by HPLC (30).
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FIGURE 8. Postulated mechanism for metabolism of acetamin-
ophen toN-acetyl-p-benzoquinone imine.
glutathione conjugate from this microsomal incuba-
tion mixture (Table 2) revealed that there was only
a 50% incorporation of molecular oxygen into the
metabolite (22). The origin of the remaining 50% of
the phenolic oxygen in the acetaminophen-glutathi-
one conjugate was investigated by synthesizing
[p-180]phenacetin and using it as a substrate in an in-
cubation mixture containing hamster liver micro-
somes, NADPH, and glutathione in the presence of
an air atmosphere (20). As shown in Table 3, the [p-
180]phenacetin used in this experiment contained
48% 110, whereas the acetaminophen-glutathione
conjugate isolated from the microsomal incubation
mixture contained 23% 1h0. Thus there was approxi-
mately a 50% loss of 180 from phenacetin during the
activation of phenacetin to a reactive metabolite
and this loss corresponded to a 50% incorporation
Table 2. Role of molecular 1502 in the
microsomal metabolism of phenacetin derivatives.a
Substrate Metabolite 180, 0/0
Acetaminophen Acetaminophen-GSH conjugate 0
Phenacetin Acetaminophen-GSH conjugate 40
Acetaminophen 0
Acetanilide Acetaminophen 80
aAcetaminophen, phenacetin, and acetanilide were incu-
bated in three separate microsomal incubation mixtures
under the same 1802 atmosphere (80% 18Q). The acetamino-
phen-glutathione conjugates were isolated from the acetamin-
ophen and phenacetin incubation mixtures. Also, acetamin-
ophen was isolated from the phenacetin and acetanilide incu-
bation mixtures. The 180 content of each metabolite was deter-
mined by mass spectrometry (22).
15
Table 3. "I0 content of acetaminophen-GSH conjugates from
0-acetaminophen and 1"0-phenacetin microsomal
incubation mixtures.a
Substrate Metabolite 180, 0/0
Acetaminophen 48
Acetaminophen-GSH conjugate 45
Phenacetin 48
Acetaminophen-GSH conjugate 23
Acetaminophen 46
aThe "0 was substituted in the 4 position of both acetamin-
ophen and phenacetin. Incubations were run in an air atmo-
sphere, and the 180 content of the metabolites was determined
by mass spectrometry (20).
of molecular oxygen into the metabolite. These find-
ings suggest that phenacetin is converted to a reac-
tive metabolite by an initial 3,4-epoxidation and that
then an intermediate is formed in which the oxygen
derived from molecular oxygen and the oxygen
from phenacetin are equivalent (20).
Further insight into the mechanism of formation
of phenacetin reactive metabolites formed by 3,4-ep-
oxidation was obtained by studying the microsomal
metabolism of [ethyl-"4C]phenacetin, [acetyl-"4C]phe-
nacetin and [ring-14C]phenacetin. Surprisingly, when
[ethyl-14C]phenacetin was incubated with micro-
somes and NADPH, covalent binding of the radio-
label to microsomal protein was observed (Table 4).
When glutathione was included in the incubation
mixture, protein covalent binding was inhibited and
a S-ethyl glutathione conjugate was formed. Deute-
rium isotope experiments using [ethyl-d5]phenace-
tin revealed that none of the protons was lost in the
formation of the S-[ethyl-d5] glutathione conjugate.
The structure of the alkylating metabolite is un-
known; however, its covalent binding to protein can
be inhibited by ascorbate (Fig. 9). Presumably, the
reactive metabolite is not the iminoquinone hemi-
ketal of phenacetin (33) since this species would be
expected to be a decomposition product of phenace-
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FIGURE 9. Effect of glutathione and ascorbic acid on covalent binding to protein of various labeled phenacetins: (U) [acetyl-
14C]phenacetin, (A) [ethyl-'4C]phenacetin, and (0) [ring-14C]phenacetin. The labeled phenacetins were incubated in separate mi-
crosomal incubation mixtures with microsomes, an NADPH generating system and varying concentrations of either glutathione
or ascorbate. In each incubation mixture covalent binding to protein was determined. Also, with [ethyl-"4C]phenacetin, a S-ethyl-
GSH conjugate (A) was quantitated, whereas with [acetyl-'4C]acetaminophen (LI) and [ring-14C]acetaminophen (0) an acetamino-
phen-GSH conjugate was quantitated.
Table 4. Comparison of microsomal metabolism of various
radiolabeled phenacetin and acetaminophen derivatives to
reactive metabolites.a
Protein
covalent binding, Acetamide,
Substrate nmole/mg/10 min nmole/mg/10 min
[Acetyl-'4C]Phenacetin 0.04 ± 0.03 2.17 0.61
[Ring-'4C]Phenacetin 1.65 ± 0.08
[Ethyl-"4C]Phenacetin 0.89 ± 0.06
[Acetyl-_4C]Acetaminophen 0.83 ± 0.02 0.18 0.03
[Ring-14C]Acetaminophen 1.07 ± 0.05
aPhenacetin metabolism and acetaminophen metabolism
were determined by using hamster liver microsomes (27, 33).
tin N-O glucuronide and [ethyl-'4C]phenacetin N-O
glucuronide does not lead to covalent binding (24).
By using the various labeled phenacetin deriva-
tives, it was also shown that covalent binding oc-
curred with [ring-14C]phenacetin; however, only
minor amounts of covalent binding occurred with
[acetyl-"C]phenacetin (Fig. 9 and Table 4). This is in
contrast to that observed with acetaminophen
where only slightly more covalent binding to pro-
tein was observed with [ring-"4C]acetaminophen
than was observed with [acetyl-'4C]acetaminophen
(27). Acetamide was a significant metabolite with
[acetyl-"C]phenacetin but a minor metabolite of
['4C]acetaminophen (Table 4). These findings indi-
cate that even though the same acetaminophen-glu-
tathione conjugate is formed from incubations of
phenacetin and acetaminophen and ascorbate inhib-
its covalent binding with both substrates (Fig. 9),
the reactive intermediates are different. Since acet-
amide is known to be formed from quinone imines,
presumably both the acetylated reactive intermedi-
ates are quinone imine derivatives. The deacety-
lated reactive metabolite, however, may be p-benzo-
quinone. This species is an electrophile and has
been previously reported to conjugate with cysteine.
Mechanism of Conversion of Phenacetin to
Reactive MetabolitesIn Vivo
The above data suggest that phenacetin may be
metabolized to reactive metabolites by at least four
different pathways: (1) N-hydroxylation followed by
sulfation or glucuronidation (17, 21, 23); (2) deethyla-
tion to acetaminophen followed by oxidation of acet-
aminophen (2 12, 13, 30); (3) N-hydroxylation fol-
lowed by O-deethylation (17, 27-29); and (4) 3,4-epoxi-
dation (20, 22, 32), (Fig. 10). Each of these mecha-
nisms yields an arylating metabolite which reacts
with glutathione to produce an acetaminophen-glu-
tathione conjugate. In vivo, this conjugate would be
further metabolized and excreted in the urine as an
acetaminophen-N-acetylcysteine conjugate (acet-
aminophen mercapturic acid) (2). The importance of
these various pathways in the in vivo metabolism of
phenacetin in hamster was investigated by studying
the metabolism of [p-'80]phenacetin to the urinary
acetaminophen mercapturic acid (20). If pathways (2)
or (3) were the major mechanisms of conversion of
phenacetin to reactive metabolites in vivo, no loss of
180 would occur in the acetaminophen mercapturic
acid. If pathway (4) were the major mechanism of
activation of phenacetin in vivo, there would be a
50% loss of '8O in the acetaminophen mercapturic
E
0
z c
z
a
u
a:
ro w
w
2.0
77J. A. HINSON
0 IF- .")
HN-C-CH3 L
1 ~~~~~0 0
OCH2CH3 'C-CH.%%%,,N-LCH3 H -C-CH3
OCH2CH3 OH
0
HN-C-CH3
CH3CH2
FIGURE 10. Mechanism of metabolism of phenacetin and acetaminophen to reactive metabolites.
Table 5. 180 Content of acetaminophen and acetaminophen
mercapturate after injection of [p-"0]phenacetin into
hamsters.a
Sample 180, % Loss of oxygen, %
Injected phenacetin 48.5 -
Acetaminophen from glucuronide 46.9 3.4
and sulfate conjugates
Acetaminophen mercapturate 44.1 9.1
aThe data presented are the average of values from t,
hamsters which received [p-180]phenacetin (50 mg/kg). Ham-
sters which received the same dose of [p-180]acetaminophen
showed a 1.5% loss of oxygen in the acetaminophen glucuro-
nide and sulfate fraction and an average 1.5% loss of 18Q in
the acetaminophen mercapturate (21).
acid. If pathway (1) were the major mechanism of
activation of phenacetin to reactive metabolite(s) in
vivo, there would be a 100% loss of 18O in the acet-
aminophen mercapturic acid. Two hamsters were
thus administered [p-180]phenacetin (50 mg/kg) and
the urinary acetaminophen mercapturic acid iso-
lated. This metabolite represented approximately
15% of the total administered dose. Mass spectral
analysis of this metabolite (Table 5) revealed ap-
proximately a 100/ loss of 18O in the acetaminophen
mercapturic acid. The data indicate that in vivo re-
active metabolites of phenacetin are formed princi-
pally by mechanisms which do not lead to loss of the
para oxygen of phenacetin such as a deethylation to
acetaminophen and subsequent activation of acet-
aminophen (pathway 2) or N-hydroxylation of phen-
acetin followed by O-deethylation toN-hydroxyacet-
aminophen which dehydrates to the reactive metab-
olite (pathway 3). Since acetaminophen is the major
metabolite of phenacetin, conversion of acetamino-
phen to a reactive metabolite may also be the major
mechanism of formation of reactive metabolites of
phenacetin. If minor loss of 18O (10%) occurs by 3,4-
epoxidation (pathway 4), then this pathway contrib-
utes 20% to the in vivo formation of this reactive
metabolite or approximately 3% of the total phen-
acetin metabolized (the mercapturate was 15% of
the total metabolites). If the 10% loss of 18O occurs
by N-hydroxylation followed by conjugation (path-
way 1), then this pathway contributes 10% of the in
vivo formation of this reactive metabolite or 1.5%
of the total metabolism (20). Data on the metabolism
of ethyl-labeled phenacetin £2) suggests that 3,4-
epoxidation may be a primary contributor to the
10°h loss of 18O in the acetaminophen mercapturate.
When ethyl-labeled phenacetin was administered to
hamsters, the S-ethyl-N-acetylcysteine and S-ethyl-
cysteine conjugates were excreted and accounted
for approximately 4% of the total dose 03). This
4% correlates quite closely with the 3% figure
which was calculated above on assuming the 10%
loss occurred solely by 3,4-epoxidation.
In conclusion, a number of pathways have been
described whereby phenacetin can be converted to
reactive metabolites. In hamsters, the primary
mechanism of activation of phenacetin to reactive
metabolites appears to be O-deethylation to acet-
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aminophen followed by activation of acetaminophen
and/or by N-hydroxylation of phenacetin followed
by O-deethylation to N-hydroxyacetaminophen
which spontaneously dehydrates. Since both acet-
aminophen and N-hydroxyacetaminophen produce
hepatic necrosis, the hepatic toxicity observed with
large doses of phenacetin in hamsters may be medi-
ated by either mechanism or by a combination of
the two.
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